학술논문
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?
Document Type
Original Paper
Author
Pane, Marika; Stanca, Giulia; Ticci, Chiara; Cutrona, Costanza; De Sanctis, Roberto; Pirinu, Matteo; Coratti, Giorgia; Palermo, Concetta; Berti, Beatrice; Leone, Daniela; Sacchini, Michele; Cerboneschi, Margherita; Fanelli, Lavinia; Norcia, Giulia; Forcina, Nicola; Capasso, Anna; Cicala, Gianpaolo; Antonaci, Laura; Ricci, Martina; Pera, Maria Carmela; Bravetti, Chiara; Donati, Maria Alice; Procopio, Elena; Abiusi, Emanuela; Vaisfeld, Alessandro; Onesimo, Roberta; Tiziano, Francesco Danilo; Mercuri, Eugenio
Source
European Journal of Pediatrics. 183(7):2995-2999
Subject
Language
English
ISSN
1432-1076
Abstract
Neonatal screening for SMA has allowed the identification of infants who may present with early clinical signs. Our aim was to establish whether the presence and the severity of early clinical signs have an effect on the development of motor milestones. Infants identified through newborn screening were prospectively assessed using a structured neonatal neurological examination and an additional module developed for the assessment of floppy infants. As part of the follow-up, all infants were assessed using the HINE-2 to establish developmental milestones. Only infants with at least 24 months of follow-up were included. Normal early neurological examination (n = 11) was associated with independent walking before the age of 18 months while infants with early clinical signs of SMA (n = 4) did not achieve ambulation (duration follow-up 33.2 months). Paucisymptomatic patients (n = 3) achieved ambulation, one before the age of 18 months and the other 2 between 22 and 24 months. Conclusion: Our findings suggest that early clinical signs may contribute to predict motor milestones development.[Table Removed]